Ophthalmologic Manifestations in Taiwanese Patients with Mucopolysaccharidoses.
Hsiang-Yu Lin,Wei-Chun Chan,Lee-Jen Chen,Yuan-Chieh Lee,Shu- Yeh,Dau-Ming Niu,Pao Chin Chiu,Wen-Hui Tsai,Wuh-Liang Hwu,Chih-Kuang Chuang,Shuan-Pei Lin
DOI: https://doi.org/10.1002/mgg3.617
2019-01-01
Molecular Genetics & Genomic Medicine
Abstract:BackgroundMucopolysaccharidoses (MPSs) are a group of rare lysosomal storage disorders characterized by the accumulation of glycosaminoglycans in various tissues and organs. Ocular problems that affect the cornea, trabecular meshwork, sclera, retina, and optic nerve are very common in these patients. However, there was limited literature focusing on comprehensive ocular findings in different types of MPS. MethodsWe retrospectively reviewed the clinical ophthalmologic features and electrodiagnostic results of 50 Taiwanese patients with a diagnosis of MPS (34 males and 16 females; age range, 1.1-34.9years; nine with MPS I, 17 with MPS II, 17 with MPS IV, and seven with MPS VI). ResultsAmong 44 patients with available data for visual acuity, 15 patients (34%) had a visual acuity of less than 0.5 (6/12) equivalent in their better eye, including 71% of those with MPS VI, 38% with MPS IV, 29% with MPS I, and 14% with MPS II. Severe corneal opacities existed in 57% of MPS VI patients and 11% of MPS I patients, compared with none for MPS II and MPS IV patients. Among 80 eyes with available data of refraction, 11 eyes (14%) had myopia (-0.50D), 55 eyes (69%) had hyperopia (0.50D), and 55 eyes (69%) had high astigmatism (1.50D). Ocular hypertension was found in 45% (28/62) of eyes. There were 16% (14/90), 11% (10/90), 13% (12/90), 31% (27/86), and 79% (30/38) of MPS eyes with lens opacities, optic disc swelling, optic disc cupped, retinopathy, and visual pathway dysfunction, respectively. Intraocular pressure was positively correlated with the severity of corneal opacity (p<0.01). ConclusionsOcular complications with significant reduction in visual acuity are common in MPS patients. Diagnostic problems may arise in these patients with severe corneal opacification, especially for those with MPS VI and MPS I.